Candidemia in Intensive Care Unit: A nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 5, 2014, Pages 661-674

  Montagna, M T ^a   Lovero, G ^a   Borghi, E ^b   Amato, G ^c   Andreoni, S ^d   Campion, L ^e   Lo Cascio, G ^f   Lombardi, G ^g   Luzzaro, F ^h   Manso, E ⁱ   Mussap, M ^j   Pecile, P ^k   Perin, S ^l   Tangorra, E ^m   Tronci, M ⁿ   Iatta, R ^a   Morace, G ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^e CA FONCELLO HOSPITAL   (Italy)

^f UNIVERSITY OF VERONA   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h Hospital A Manzoni   (Italy)

ⁱ OSPEDALI RIUNITI   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l SAN CARLO BORROMEO HOSPITAL   (Italy)

^m Department of Experimental Diagnostic and Specialty Medicine ^*  (Italy)

ⁿ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

more..

Author keywords

Candida spp; Candidemia; Intensive Care Unit; Literature review; Yeast infections

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CORTICOSTEROID; FLUCONAZOLE; GLUCOCORTICOID;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CLINICAL EVALUATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EUROPE; FEMALE; FRANCE; FUNGAL STRAIN; GREECE; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; ITALY; MAJOR CLINICAL STUDY; MALE; MEDLINE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PROSPECTIVE STUDY; RISK FACTOR; SPAIN; SPECIES DISTRIBUTION; TURKEY (REPUBLIC); UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT; PROCEDURES; QUESTIONNAIRE; TRENDS; TURKEY;

ADULT; ANTIFUNGAL AGENTS; CANDIDEMIA; EUROPE; FRANCE; GREECE; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVEYS AND QUESTIONNAIRES; TURKEY;

EID: 84897017842     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. MORACE G, BORGHI E. Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol 2010; 76: 950-956.
2. KETT DH, AZOULAY E, ECHEVERRIA PM, VINCENT JL. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011; 39: 665-670.
3. VINCENT JL, RELLO J, MARSHALL J, SILVA E, ANZUETO A, MARTIN CD, MORENO R, LIPMAN J, GOMERSALL C, SAKR Y, REINHART K. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-2329.
4. GUERY BP, ARENDRUP MC, AUZINGER G, AZOULAY E, BORGES SA M, JOHNSON EM, MULLER E, PUTENSEN C, ROTSTEIN C, SGANGA G, VENDITTI M, ZARAGOZA CRESPO R, KULLBERG BJ. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 2009; 35: 55-62.
5. PFALLER MA, MESSER SA, MOET GJ, JONES RN, CASTANHEIRA M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38: 65-69.
6. BASSETTI M, MIKULSKA M, VISCOLI C. Bench-tobedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care 2010; 14: 244.
7. CHOW JK, GOLAN Y, RUTHAZER R, KARCHMER AW, CARMELI Y, LICHTENBERG D, CHAWLA V, YOUNG J, HADLEY S. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008; 46: 1206-1213.
8. LEROY O, GANGNEUX JP, MONTRAVERS P, MIRA JP, GOUIN F, SOLLET JP, CARLET J, REYNES J, ROSENHEIM M, REGNIER B, LORTHOLARY O. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-1618.
9. PLAYFORD EG, MARRIOTT D, NGUYEN Q, CHEN S, ELLIS D, SLAVIN M, SORRELL TC. Candidemia in nonneutropenic critically ill patients: risk factors for nonalbicans Candida spp. Crit Care Med 2008; 36: 2034-2039.
10. HORASAN ES, ERSOZ G, GOKSU M, OTAG F, KURT AO, KARACORLU S, KAYA A. Increase in Candida parapsilosis fungemia in critical care units: a 6-years study. Mycopathologia 2010; 170: 263-268.
11. NUCCI M, QUEIROZ-TELLES F, TOBON AM, RESTREPO A, COLOMBO AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51: 561-570.
12. PRATIKAKI M, PLATSOUKA E, SOTIROPOULOU C, DOUKA E, PARAMYTHIOTOU E, KALTSAS P, KOTANIDOU A, PANIARA O, ROUSSOS C, ROUTSI C. Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit. Mycoses 2011; 54: 154-161.
13. TORTORANO AM, DHO G, PRIGITANO A, BREDA G, GRANCINI A, EMMI V, CAVANNA C, MARINO G, MORERO S, OSSI C, DELVECCHIO G, PASSERA M, CUSUMANO V, DAVID A, BONACCORSO G, CORONA A, FAVARO M, VISMARA C, GARAU MG, FALCHI S, TEJADA MR. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses 2012; 55: 73-79.
14. BASSETTI M, RIGHI E, COSTA A, FASCE R, MOLINARI MP, ROSSO R, PALLAVICINI FB, VISCOLI C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006; 6: 21.
15. CAGGIANO G, IATTA R, LANEVE A, MANCA F, MONTAGNA MT. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004. Mycoses 2008; 51: 123-128.
16. MONTAGNA MT, CAGGIANO G, LOVERO G, DE GIGLIO O, CORETTI C, CUNA T, IATTA R, GIGLIO M, DALFINO L, BRUNO F, PUNTILLO F. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection 2013; 41: 645-653.
17. MORACE G, BORGHI E, IATTA R, AMATO G, ANDREONI S, BRIGANTE G, FARINA C, LO CASCIO G, LOMBARDI G, MANSO E, MUSSAP M, PECILE P, RIGOLI R, TANGORRA E, VALMARIN M, MONTAGNA MT. Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients. BMC Infect Dis 2011; 11:130.
18. ALMIRANTE B, RODRIGUEZ D, PARK BJ, CUENCA-ESTRELLA M, PLANES AM, ALMELA M, MENSA J, SANCHEZ F, AYATS J, GIMENEZ M, SABALLS P, FRIDKIN SK, MORGAN J, RODRIGUEZ- TUDELA JL, WARNOCK DW, PAHISSA A. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population- based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829-1835.
19. ARENDRUP MC, SULIM S, HOLM A, NIELSEN L, NIELSEN SD, KNUDSEN JD, DRENCK NE, CHRISTENSEN JJ, JOHANSEN HK. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011; 49: 3300-3308.
20. BASSETTI M, TARAMASSO L, NICCO E, MOLINARI MP, MUSSAP M, VISCOLI C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6: e24198.
21. BOUGNOUX ME, KAC G, AEGERTER P, D'ENFERT C, FAGON JY. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008; 34: 292-299.
22. COHEN Y, KAROUBI P, ADRIE C, GAUZIT R, MARSEPOIL T, ZARKA D, CLEC'H C. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med 2010; 38: 826-830.
23. DAS I, NIGHTINGALE P, PATEL M, JUMAA P. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 2011; 15: e759-763.
24. DIMOPOULOS G, NTZIORA F, RACHIOTIS G, ARMAGANIDIS A, FALAGAS ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008; 106: 523-529.
25. GURCUOGLU E, ENER B, AKALIN H, SINIRTAS M, EVCI C, AKCAGLAR S, YILMAZ E, HEPER Y. Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study. Epidemiol Infect 2010; 138: 1328-1335.
26. HOLLEY A, DULHUNTY J, BLOT S, LIPMAN J, LOBO S, DANCER C, RELLO J, DIMOPOULOS G. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int J Antimicrob Agents 2009; 33: 554 e551-557.
27. LAGROU K, VERHAEGEN J, PEETERMANS WE, DE RIJDT T, MAERTENS J, VAN WIJNGAERDEN E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 2007; 26: 541-547.
28. LEROY O, MIRA JP, MONTRAVERS P, GANGNEUX JP, LORTHOLARY O. Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care 2010; 14: R98.
29. NAWROT U, PAJACZKOWSKA M, FLEISCHER M, PRZONDO-MORDARSKA H, SAMET A, PIASECKA-PAZIK D, KOMARNICKA J, SULIK-TYSZKA B, SWOBODA-KOPEC E, CIESLIK J, MIKUCKA A, GOSPODAREK E, OZOROWSKI T, MOL A, TRYNISZEWSKA E, KLOSOWSKA W, KRAWCZYK M, GOLEC K, SZYMANIAK L, GIEDRYS-KALEMBA S, BILSKA I, PRAWDA-ZOLOTAR J, JUSZCZYK-GRUDZINSKA M, WROBLEWSKA M, BURDYNOWSKI K. Candidaemia in polish hospitals - a multicentre survey. Mycoses 2013; 56: 576-581.
30. PARMELAND L, GAZON M, GUERIN C, ARGAUD L, LEHOT JJ, BASTIEN O, ALLAOUCHICHE B, MICHALLET M, PICOT S, BIENVENU AL. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol 2013; 51: 33-37.
31. PRESTERL E, DAXBOCK F, GRANINGER W, WILLINGER B Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect 2007; 13: 1072-1076.
32. VARDAKAS KZ, MICHALOPOULOS A, KIRIAKIDOU KG, SIAMPLI EP, SAMONIS G, FALAGAS ME Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect 2009; 15: 289-292.
33. YLIPALOSAARI P, ALA-KOKKO TI, KARHU J, KOSKELA M, LAURILA J, OHTONEN P, SYRJALA H. Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment. Crit Care 2012; 16: R62.
34. COSTA-DE-OLIVEIRA S, PINA-VAZ C, MENDONCA D, GONCALVES RODRIGUES A. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis 2008; 27: 365-374.
35. PEMAN J, CANTON E, QUINDOS G, ERASO E, ALCOBA J, GUINEA J, MERINO P, RUIZ-PEREZ-DE-PIPAON MT, PEREZDEL-MOLINO L, LINARES-SICILIA MJ, MARCO F, GARCIA J, ROSELLO EM, GOMEZ GD-L-PE, BORRELL N, PORRAS A, YAGUE G. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67: 1181-1187.
36. DIZBAY M, FIDAN I, KALKANCI A, SARI N, YALCIN B, KUSTIMUR S, ARMAN D. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility. Scand J Infect Dis 2010; 42: 114-120.
37. EGGIMANN P, GARBINO J, PITTET D. Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003; 3: 772-785.
38. FALAGAS ME, ROUSSOS N, VARDAKAS KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: e954-966.
39. MAGILL SS, SWOBODA SM, SHIELDS CE, COLANTUONI EA, FOTHERGILL AW, MERZ WG, LIPSETT PA, HENDRIX CW. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Ann Surg 2009; 249: 657-665.
40. PFALLER MA, DIEKEMA DJ Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163.
41. CHAHOUD J, KANAFANI ZA, KANJ SS. Management of candidaemia and invasive candidiasis in critically ill patients. Int J Antimicrob Agents 2013; 42 Suppl: S29-35.
42. HOBSON RP. The global epidemiology of invasive Candida infections-is the tide turning? J Hosp Infect 2003; 55: 159-168.
43. MUSKETT H, SHAHIN J, EYRES G, HARVEY S, ROWAN K, HARRISON D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care 2011; 15: R287.
44. JORDA-MARCOS R, ALVAREZ-LERMA F, JURADO M, PALOMAR M, NOLLA-SALAS J, LEON MA, LEON C. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007; 50: 302-310.
45. SARDI JC, SCORZONI L, BERNARDI T, FUSCO-ALMEIDA AM, MENDES GIANNINI MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013; 62 (Pt 1): 10-24.
46. SHORR AF, LAZARUS DR, SHERNER JH, JACKSON WL, MORREL M, FRASER VJ, KOLLEF MH Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of nonalbicans candidemia. Crit Care Med 2007; 35: 1077-1083.
47. TROFA D, GACSER A, NOSANCHUK JD Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008;21: 606-625.